{"filing":{"accession_number":"0001185185-26-003124","cik":"0001864531","ticker":"VSEEW","company_name":"VSEE HEALTH, INC.","form":"8-K","filing_date":"2026-07-24","report_date":"2026-07-21","primary_document":"vsee8k072426.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1864531/000118518526003124/vsee8k072426.htm"},"events":[{"id":20489,"run_id":18441,"accession_number":"0001185185-26-003124","anchor_item_number":"3.02","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"summary":"VSee Health issued 1 million restricted shares and two promissory notes (totaling $50K–$125K) to settle disputes with a creditor regarding covenant breaches on an existing debt instrument, including failure to file registration statements and transfer agent instructions.","company_name":"VSEE HEALTH, INC.","ticker":"VSEEW","filing_date":"2026-07-24","form":"8-K","submitted_at":null,"items":[{"id":19859,"accession_number":"0001185185-26-003124","item_number":"1.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.45,"reasoning":"This disclosure centers on a Settlement Agreement resolving disputes arising from an existing debt instrument (the Existing Note) and related financing transactions. While Item 1.01 is titled \"Entry into a Material Definitive Agreement,\" the substance involves settlement of a covenant breach dispute (ADI's notice of default for failure to file registration statements and transfer agent instructions) rather than a traditional M\u0026A transaction. The settlement requires significant dilutive issuances (1 million restricted shares) and new debt obligations (two $50K-$125K promissory notes), making it material to investors, but the core event is dispute resolution tied to existing obligations rather than a new acquisition or disposition.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-24T20:33:41.125585+00:00","company_name":"","ticker":null,"filing_date":""},{"id":19860,"accession_number":"0001185185-26-003124","item_number":"3.02","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Item 3.02 discloses unregistered sales of equity securities — specifically \"Settlement Notes and Settlement Shares\" issued under a Settlement Agreement in a transaction exempt from registration under Section 4(a)(2) of the Securities Act. This is a classic dilutive issuance of equity securities outside the registered offering process, material to investors assessing ownership dilution and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-24T20:33:41.125585+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":19859,"accession_number":"0001185185-26-003124","item_number":"1.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.45,"reasoning":"This disclosure centers on a Settlement Agreement resolving disputes arising from an existing debt instrument (the Existing Note) and related financing transactions. While Item 1.01 is titled \"Entry into a Material Definitive Agreement,\" the substance involves settlement of a covenant breach dispute (ADI's notice of default for failure to file registration statements and transfer agent instructions) rather than a traditional M\u0026A transaction. The settlement requires significant dilutive issuances (1 million restricted shares) and new debt obligations (two $50K-$125K promissory notes), making it material to investors, but the core event is dispute resolution tied to existing obligations rather than a new acquisition or disposition.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-24T20:33:41.125585+00:00","company_name":"VSEE HEALTH, INC.","ticker":"VSEEW","filing_date":"2026-07-24"},{"id":19860,"accession_number":"0001185185-26-003124","item_number":"3.02","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Item 3.02 discloses unregistered sales of equity securities — specifically \"Settlement Notes and Settlement Shares\" issued under a Settlement Agreement in a transaction exempt from registration under Section 4(a)(2) of the Securities Act. This is a classic dilutive issuance of equity securities outside the registered offering process, material to investors assessing ownership dilution and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-24T20:33:41.125585+00:00","company_name":"VSEE HEALTH, INC.","ticker":"VSEEW","filing_date":"2026-07-24"}]}